Liberal Democrats Senator David Leyonhjelm is pushing for the Federal Government to break the barriers preventing thousands of Australians suffering from chronic pain from accessing medicinal cannabis. Senator Leyonhjelm comments come ahead of HEMP Embassy campaigners protesting against the restrictions on cannabis use as the prescription-only rules for codeine come into effect.
Senator Leyonhjelm commented that “it has now become a matter of urgency that seriously ill patients obtain access to an effective and safe alternative.”
Read the article here.
We’re thrilled to announce we have received our export licence from the Drug Control Section of the ODC (Office of Drug Control). We’re firmly on course to continue to lead the way and be the first medicinal cannabis company in Australia to export cannabis flower to the EU since export was legalised in 2018.
One of ANTG’s proprietary medicinal cannabis strains, EVE Cannabis Indica, has been listed on the Australian Register of Therapeutic Goods (ARTG). The ARTG is a reference of therapeutic goods that can lawfully be supplied in or exported from Australia.
We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.LEARN ABOUT ANTG HERE >